Stimulation system with percutaneously deliverable paddle lead and methods of making and using

• US 9,492,655 B2
• Filed: 04/23/2009
• Issued: 11/15/2016
• Est. Priority Date: 04/25/2008
• Status: Active Grant

• Current Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Inventors: Pianca, Anne Margaret, Gould, Christopher B., Krueger, Joel Adam
• Primary Examiner(s): Koharski, Christopher D
• Assistant Examiner(s): MAHMOOD, NADIA AHMAD
• Application Number:
  US12/428,978
• Publication Number:
  US 20090270957A1
• Time in Patent Office: 2,763 Days
• Field of Search: 607/116, 607/117
• US Class Current: 1/1
• CPC Class Codes: A61N 1/0553 Paddle shaped electrodes, e.g. for laminotomy

Abstract

An implantable lead includes an expandable paddle body and a plurality of electrodes disposed on the paddle body. The electrodes are configured and arranged to provide electrical stimulation to adjacent tissue when implanted and the lead is coupled to a control module. The paddle body is configured for percutaneous implantation through an introducer followed by expansion of a volume of the paddle body by at least 10%. Alternatively, the paddle body is configured for percutaneous implantation and when implanted the lead is configured and arranged so that a position or orientation of the plurality of electrodes relative to the paddle body can be altered.

Claims

1. An implantable lead, comprising:

an expandable paddle body, wherein the paddle body is configured for percutaneous implantation through an introducer followed by expansion of a volume of the paddle body by at least 10%, wherein the paddle body comprises an expandable mesh configured and arranged to permit expansion of the mesh after implantation of the lead; and

a plurality of electrodes disposed on the paddle body and configured and arranged to provide electrical stimulation to adjacent tissue when implanted with the lead coupled to a control module.

2. The implantable lead of claim 1, wherein the paddle body is configured and arranged for expansion by inserting a fluid into the paddle body.

3. The implantable lead of claim 2, wherein the paddle body is configured and arranged for deflation over a period of time after expansion.

4. The implantable lead of claim 1, wherein at least one of the electrodes has an identification feature to allow determination of an orientation of implantation of the lead by observation of the identification feature.

5. The implantable lead of claim 4, wherein the identification feature is at least one indentation asymmetrically positioned in a shape of the at least one electrode.

6. A kit for implanting a lead, comprising:

the implantable lead of claim 1; and

an introducer through which the paddle body of the lead can be percutaneously implanted into tissue of a body and then withdrawn from the lead.

7. The kit of claim 6, wherein the introducer is a needle introducer that comprises a plurality of windows configured and arranged to permit stimulation of tissue adjacent to at least one of the plurality of windows by alignment of at least one of the electrodes of the implantable lead with the at least one of the plurality of windows while the lead is still disposed within the needle introducer.

8. A kit for implanting a lead, comprising:

a lead comprising a paddle body with a plurality of electrodes disposed on the paddle body, wherein at least one of the electrodes has an identification feature to allow determination of an orientation of implantation of the lead by observation of the identification feature; and

a needle introducer with a non-circular, closed-path, transverse cross section through which the paddle body of the lead can be percutaneously implanted into tissue of a body and then withdrawn from the lead, wherein the needle introducer comprises a plurality of windows configured and arranged permit stimulation of tissue adjacent to at least one of the plurality of windows by alignment of at least one of the electrodes of the lead with the at least one of the plurality of windows while still disposed within the needle introducer.

9. The kit of claim 8, wherein the identification feature is at least one indentation in a shape of the at least one electrode.

10. An implantable lead, comprising:

a paddle body; and

a plurality of electrodes disposed on the paddle body and configured and arranged to provide electrical stimulation to adjacent tissue when implanted with the lead coupled to a control module, wherein the paddle body is configured for percutaneous implantation and when implanted the lead is configured and arranged so that a position or orientation of the plurality of electrodes relative to a portion of the paddle body immediately adjacent to the electrodes is alterable.

11. The implantable lead of claim 10, further comprising a plurality of hinges, wherein the plurality of electrodes are each coupled to a one of the plurality of hinges that allows the electrode to change position or orientation with respect to the portion of the paddle body immediately adjacent to the electrodes.

12. A method for percutaneous implantation of a lead of an electrical stimulation system, the method comprising:

inserting an introducer through skin of a patient with at least a portion of the lead disposed in the introducer, the lead comprising a paddle body with a plurality of electrodes disposed on the paddle body;

positioning the lead near tissue to be stimulated including observing an identification feature on at least one of the electrodes to determine an orientation of implantation of the lead, wherein the identification feature comprises at least one indentation asymmetrically positioned on the shape of the at least one of the electrodes;

withdrawing the introducer leaving the lead implanted in the patient; and

expanding a volume of the paddle body by at least 10% after implanting the lead.

13. The method of claim 12, wherein expanding the paddle body comprises introducing a fluid into the paddle body.

14. The method of claim 12, further comprising deflating the paddle body after a period of time has elapsed from expanding the paddle body.

15. The method of claim 12, wherein positioning the lead comprises stimulating adjacent tissue through windows in the introducer using electrodes on the lead which are aligned with the windows in the introducer.

16. The method of claim 12, wherein the introducer is a needle introducer and the introducer has a non-circular, closed-path, transverse cross-section through which the paddle body of the lead can be percutaneously implanted into tissue of a body.